{"path":"Images/Pasted image 20240219173021.png","text":"General principles « Act promptly to minimize blood loss « Establish Jehovah's Witness status and capacity, competence, legal issues, and advance directive * Determine acceptable therapies * Plan for worst case scenario + Establish cause or source of bleeding; medical or surgical + Provide thorough documentation « Early consultant involvement and referral « Close monitoring and limited phlebotomy + Low threshold for high-dependency unit/intensive care unit Targeted therapies to be enacted simultaneously B akon boed bas oun nce ::r-mmwmummm Comrc conpton deacta end pecte * Prompt surgical intervention Maximize oxygen delivery * Iron sucrose 200 mg .v. three times per * Maintain normothermia and stop * Replace intravascular volume « Supplemental 0, week drugs that impair clotting « Vitamin By, 1 mgiv. once daily Discuss with consultant haematologist « Treat underlying I hol o GO the fohote ot iderying Ty petholegy « Folate 20 mg L. on alterate days « Cryoprecipitate (if acceptable) one pack « Cell salvage Consider the following + Recombinant erythropoietin 600 g per 10 kg body weight * Washing and reinfusion of drain fluid « Intubation/ventilation kg (regimens vary; can be up to daily) * Prothrombin complex concentrate * Arterial toumiquets % Cardiopulmons 20-50pg kg™ « Interventional radiology bk sy n’imh’m“'n'; Vitamin K 10 mgiv. Acute hypervolaemic haemodilution o * Tranexamic acid 1giv. every 6 h i s ‘oxygenation, or hyperbaric therapy A o Permissive hypotension el * Desmopressin 0.3 pg kg * in * Medical treatments, such as 50 ml saline over 30 min uterotonics for uterine bleeding :::n: 0, uptake and metabolic Consider the following: + Treat shock and maintain . :I:?:,wlen concentrate (if acceptable) cardiac output Factor VIl and IX replacement Consider the following: Recombinant factor Vila 40-65 g kg™ + Aprotinin * Sedation « Paralysis. * Cooling","libVersion":"0.3.2","langs":"eng"}